Cargando…

Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma

BACKGROUND: Progesterone receptors play a key role in the development of canine mammary tumours, and recent research has focussed on their possible value as therapeutic targets using antiprogestins. Cloning and sequencing of the progesterone receptor gene has shown that the receptor has two isoforms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guil-Luna, Silvia, Stenvang, Jan, Brünner, Nils, De Andrés, Francisco Javier, Rollón, Eva, Domingo, Víctor, Sánchez-Céspedes, Raquel, Millán, Yolanda, Martín de las Mulas, Juana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280049/ https://www.ncbi.nlm.nih.gov/pubmed/25515784 http://dx.doi.org/10.1186/s12917-014-0296-2

Ejemplares similares

Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study
por: Ordás, Javier, et al.
Publicado: (2007)

Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
por: Maniscalco, Lorella, et al.
Publicado: (2013)

Evaluation of aglepristone and oxytocin on induction of parturition in guinea pig
por: Sara, Tayeban, et al.
Publicado: (2023)

Use of aglepristone for the treatment of P(4) induced insulin resistance in dogs
por: Bigliardi, Enrico, et al.
Publicado: (2014)

Analysis of cell-free DNA concentration, fragmentation patterns and TP53 gene expression in mammary tumor-bearing dogs: A pilot study
por: Guil-Luna, Silvia, et al.
Publicado: (2023)

Utero-Placental Immune Milieu during Normal and Aglepristone-Induced Parturition in the Dog
por: Tavares Pereira, Miguel, et al.
Publicado: (2021)

Aglepristone Administration in Mid-Proestrus Reduces the LH Peak but Does Not Prevent Ovulation in the Bitch
por: Socha, Piotr, et al.
Publicado: (2021)

Vitamin D receptor (VDR) expression in different molecular subtypes of canine mammary carcinoma
por: Sánchez-Céspedes, R., et al.
Publicado: (2021)

Changes in Ovaries and Uterus after Aglepristone Administration in the Third Week of Luteal Phase of Non-Pregnant Bitches
por: Kacprzak, Kamil, et al.
Publicado: (2015)

Firocoxib as a Potential Neoadjuvant Treatment in Canine Patients with Triple-Negative Mammary Gland Tumors
por: Brandi, Andressa, et al.
Publicado: (2022)

Isoform specificity of progesterone receptor antibodies
por: Fabris, Victoria, et al.
Publicado: (2017)

Lack of in vitro effect of aglepristone on IFN-γ and IL-4 production by resting and mitogen-activated T cells of luteal bitches
por: Jurka, Piotr, et al.
Publicado: (2013)

Decreased Size of Mammary Tumors Caused by Preoperative Treatment with Aglepristone in Female Domestic Dogs (Canis familiaris) Do Not Influence the Density of the Benign Neoplastic Tissue Measured Using Shear Wave Elastography Technique
por: Pieczewska, Barbara, et al.
Publicado: (2021)

Progesterone through Progesterone Receptor B Isoform Promotes Rodent Embryonic Oligodendrogenesis
por: González-Orozco, Juan Carlos, et al.
Publicado: (2020)

Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas
por: Michel, Erika, et al.
Publicado: (2012)

Progesterone Concentrations during Canine Pregnancy
por: Hinderer, Janna, et al.
Publicado: (2021)

Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progression
por: Grindstad, Thea, et al.
Publicado: (2018)

Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer
por: Zambrano-Estrada, Xóchitl, et al.
Publicado: (2018)

Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands
por: Carlini, María José, et al.
Publicado: (2018)

Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
por: Kreizman-Shefer, Hila, et al.
Publicado: (2014)

Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Induces Local and Systemic Antitumor Efficacy in Canine Mammary Cancer Patients
por: Valdivia, Guillermo, et al.
Publicado: (2023)

Canine Mammary Mixed Tumours: A Review
por: Dantas Cassali, Geovanni, et al.
Publicado: (2012)

Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer
por: Alonso-Miguel, Daniel, et al.
Publicado: (2022)

Progesterone receptor isoforms A and B: new insights into the mechanism of progesterone resistance for the treatment of endometrial carcinoma
por: Shao, Ruijin
Publicado: (2013)

Prognostic phenotypic classification for canine mammary tumors
por: Varallo, Giovanna Rossi, et al.
Publicado: (2019)

Modulation of Progesterone Receptor Isoform Expression in Pregnant Human Myometrium
por: Ilicic, Marina, et al.
Publicado: (2017)

Characterization of Nuclear Progesterone Receptor Isoforms in the Term Equine Placenta
por: Nagy, Ahmed M., et al.
Publicado: (2021)

Intraovarian, Isoform-Specific Transcriptional Roles of Progesterone Receptor in Ovulation
por: Smith, Kirsten M., et al.
Publicado: (2022)

Regulation of progesterone receptor signaling by BRCA1 in mammary cancer
por: Katiyar, Pragati, et al.
Publicado: (2006)

Progesterone promotes immunomodulation and tumor development in the murine mammary gland
por: Werner, Lauryn R, et al.
Publicado: (2021)

Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression
por: Scarpin, Katherine M., et al.
Publicado: (2009)

Progesterone receptor antagonists reverse stem cell expansion and the paracrine effectors of progesterone action in the mouse mammary gland
por: Ranjan, Manish, et al.
Publicado: (2021)

Comparison of progesterone assay by chemiluminescence or radioimmunoassay for clinical decision-making in canine reproduction
por: Nöthling, Johan O., et al.
Publicado: (2019)

Comparative mammary oncology: canine model
por: Cassali, Geovanni Dantas
Publicado: (2013)

Prevalence of Glomerulopathies in Canine Mammary Carcinoma
por: Crivellenti, Leandro Z., et al.
Publicado: (2016)

Current biomarkers of canine mammary tumors
por: Kaszak, Ilona, et al.
Publicado: (2018)

Epigenetic alterations in canine mammary cancer
por: Borges, Bárbara do Nascimento
Publicado: (2022)

Metabolic Alterations in Canine Mammary Tumors
por: Tamarindo, Guilherme Henrique, et al.
Publicado: (2023)

Epidemiology of canine mammary tumours on the Canary Archipelago in Spain
por: Rodríguez, José, et al.
Publicado: (2022)

Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling
por: Singhal, Hari, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_06tlvt0pmdj052sa190k5inhb2